Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Research & Development (2020 - 2025)

Celularity (CELU) has disclosed Research & Development for 6 consecutive years, with $4.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development rose 17.45% to $4.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $15.5 million, a 16.71% increase, with the full-year FY2024 number at $17.4 million, down 42.93% from a year prior.
  • Research & Development was $4.6 million for Q3 2025 at Celularity, up from $3.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $25.3 million in Q2 2022 to a low of -$272000.0 in Q4 2023.
  • A 5-year average of $11.9 million and a median of $8.6 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: crashed 102.47% in 2023, then surged 1507.35% in 2024.
  • Celularity's Research & Development stood at $24.7 million in 2021, then tumbled by 55.48% to $11.0 million in 2022, then crashed by 102.47% to -$272000.0 in 2023, then soared by 1507.35% to $3.8 million in 2024, then grew by 20.11% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Research & Development are $4.6 million (Q3 2025), $3.4 million (Q2 2025), and $3.7 million (Q1 2025).